This chronic model is steroid insensitive and less sensitive to therapeutic intervention with the TLR7 and TLR9 agonist resiquimod or CpG-ODN than other published severe asthma models [12], [40], [46], [47]. The gene discussed is TLR9; the disease is asthma.